- Home
- GEL vs ANAB Comparison
GEL vs ANAB Comparison
Compare GEL & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GEL | ANAB |
|---|---|---|
| Founded | 1996 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GEL | ANAB |
|---|---|---|
| Price | $13.60 | $48.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $18.33 | ★ $88.50 |
| AVG Volume (30 Days) | 257.2K | ★ 441.4K |
| Earning Date | 10-29-2026 | 09-21-2026 |
| Dividend Yield | ★ 5.81% | N/A |
| EPS Growth | N/A | ★ 91.02 |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $2,912,770,000.00 | $234,603,000.00 |
| Revenue This Year | $9.79 | $17.97 |
| Revenue Next Year | N/A | $36.88 |
| P/E Ratio | $65.86 | ★ N/A |
| Revenue Growth | 43.60 | ★ 157.01 |
| 52 Week Low | $13.75 | $29.49 |
| 52 Week High | $18.64 | $73.30 |
Technical Indicators
Market Signals| Indicator | GEL | ANAB |
|---|---|---|
| Relative Strength Index (RSI) | 25.30 | 33.62 |
| Support Level | N/A | $49.93 |
| Resistance Level | $15.28 | $51.67 |
| Average True Range (ATR) | 0.40 | 2.07 |
| MACD | -0.17 | -0.37 |
| Stochastic Oscillator | 0.11 | 13.66 |
Price Performance
Historical ComparisonAbout GEL Genesis Energy L.P.
Genesis Energy LP focuses on the midstream segment of the crude oil and natural gas industry. It offers various services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are: Offshore pipeline transportation, Marine transportation, and Onshore transportation and services. Maximum revenue is generated from the Offshore pipeline transportation segment, which includes the transportation and processing of crude oil and natural gas in the Gulf of America. The Marine transportation segment provides waterborne transportation of petroleum products and crude oil throughout North America; and the Onshore transportation and services segment deals with crude oil logistics, sour gas processing, and sells sulfur byproducts.
About ANAB AnaptysBio Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).